MCD
52
2
TJX
64
2
MET
72
5
DD
63
3
LEG
36
4
TSCO
49
5
DVN
21
3
BBY
46
10
CTSH
56
2
AAP
24
6
A
43
2
SO
53
-4
NRG
49
-3
CF
57
-2
SIG
52
3
CPB
30
6
VZ
50
3
EL
25
4
GPC
40
3
RIG
60
2
MCD
52
2
TJX
64
2
MET
72
5
DD
63
3
LEG
36
4
TSCO
49
5
DVN
21
3
BBY
46
10
CTSH
56
2
AAP
24
6
A
43
2
SO
53
-4
NRG
49
-3
CF
57
-2
SIG
52
3
CPB
30
6
VZ
50
3
EL
25
4
GPC
40
3
RIG
60
2
Financhill
Back

Denali Therapeutics Vs. Perspective Therapeutics Industry Stock Comparison

Sell
35

DNLI
Denali Therapeutics

Last Price:
24.70
Seasonality Move:
7.97%
Sell
30

CATX
Perspective Therapeutics

Last Price:
3.49
Seasonality Move:
34.33%
Sell
35
Denali Therapeutics (DNLI) is a Sell

Is Denali Therapeutics a Buy, Sell or Hold?

  • The current Denali Therapeutics [DNLI] share price is $24.69. The Score for DNLI is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • DNLI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.47. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DNLI Stock Price Chart

What is Denali Therapeutics's stock price today?

  • The Denali Therapeutics share price today is $24.69
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DNLI is experiencing buying pressure, which is a positive indicator for future bullish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.

DNLI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.77 Sell
Relative Strength Index (14 RSI): 38.85 Sell
Chaikin Money Flow: 742863 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (24.99 - 29.27) Sell
Bollinger Bands (100): (22.95 - 28.61) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.06 Sell
Relative Strength Index (14 RSI): 14.31 Sell
Chaikin Money Flow: 5909257 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.39 - 12.93) Sell
Bollinger Bands (100): (10.25 - 14.79) Sell

DNLI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 25.62 Sell
20-day SMA: 27.35 Sell
50-day SMA: 27.95 Sell
200-day SMA: 22.57 Buy
8-day EMA: 25.54 Sell
20-day EMA: 26.7 Sell
50-day EMA: 26.88 Sell
200-day EMA: 24.19 Buy

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.64 Sell
20-day SMA: 9.7 Sell
50-day SMA: 11.58 Sell
200-day SMA: 12.72 Sell
8-day EMA: 6.25 Sell
20-day EMA: 8.74 Sell
50-day EMA: 10.88 Sell
200-day EMA: 11.36 Sell

Denali Therapeutics Earnings Growth & DNLI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.78 per share, and a decrease next year of $0.10 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.

Denali Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):